Update on Paraneoplastic Cerebellar Degeneration

Area of Science:

• Neurology
• Oncology
• Immunology

Background:

• Paraneoplastic cerebellar degeneration (PCD) is a significant neurological manifestation associated with underlying malignancies.
• It is a leading cause of immune-mediated cerebellar ataxias (IMCAs), presenting as a rapidly progressive cerebellar syndrome.

Purpose of the Study:

• To provide an updated review of paraneoplastic cerebellar degeneration (PCD).
• To discuss associated antibodies, tumors, and current management strategies.
• To highlight recent advancements in diagnostic criteria and approaches.

Main Methods:

• Review of recent literature on PCD, associated antibodies, and tumors.
• Analysis of updated diagnostic criteria for paraneoplastic neurologic symptoms.
• Discussion of clinical presentations and management strategies.

Main Results:

• PCD is a frequent paraneoplastic presentation characterized by rapid cerebellar syndrome.
• Several novel antibodies have been identified in association with PCD, though their clinical significance requires further determination.
• Updated diagnostic criteria aid in PCD diagnosis, cancer screening, and antibody evaluation.

Conclusions:

• Prompt recognition of PCD and identification of specific antibodies are crucial for early cancer detection and effective treatment.
• The clinical course of PCD can be modulated by timely intervention.
• Continuous patient surveillance is recommended as symptoms may precede tumor diagnosis by years.